Capital International Sarl - AGIOS PHARMACEUTICALS INC ownership

AGIOS PHARMACEUTICALS INC's ticker is AGIO and the CUSIP is 00847X104. A total of 201 filers reported holding AGIOS PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 1.35 and the average weighting 0.1%.

Quarter-by-quarter ownership
Capital International Sarl ownership history of AGIOS PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2020$287,000
-32.3%
8,198
+3.3%
0.04%
-37.5%
Q2 2020$424,000
+88.4%
7,934
+25.1%
0.06%
+36.6%
Q1 2020$225,000
-82.0%
6,340
-75.7%
0.04%
-78.9%
Q4 2019$1,248,000
+73.6%
26,131
+17.7%
0.19%
+56.5%
Q3 2019$719,000
-51.8%
22,200
-25.8%
0.12%
-40.4%
Q2 2019$1,491,000
-26.0%
29,9000.0%0.21%
-17.5%
Q1 2019$2,016,000
+27.1%
29,900
-13.1%
0.25%
+31.9%
Q4 2018$1,586,000
-40.2%
34,4000.0%0.19%
-24.5%
Q3 2018$2,653,000
+16.2%
34,400
+26.9%
0.25%
+9.5%
Q2 2018$2,283,000
+3.0%
27,1000.0%0.23%
+8.5%
Q1 2018$2,216,000
+18.9%
27,100
-16.9%
0.21%
+22.4%
Q4 2017$1,864,000
-78.7%
32,600
-75.1%
0.17%
-76.0%
Q3 2017$8,731,000
+10.1%
130,800
-15.1%
0.73%
+6.1%
Q2 2017$7,928,000
-11.3%
154,100
+0.7%
0.68%
-11.3%
Q1 2017$8,941,000
+31.9%
153,100
-5.8%
0.77%
+24.0%
Q4 2016$6,781,000
-12.9%
162,500
+10.2%
0.62%
-5.6%
Q3 2016$7,786,000
+26.1%
147,4000.0%0.66%
+25.3%
Q2 2016$6,175,000
+30.3%
147,400
+26.3%
0.53%
+30.8%
Q1 2016$4,738,000
-37.5%
116,7000.0%0.40%
-37.2%
Q4 2015$7,576,000
+32.0%
116,700
+43.5%
0.64%
+24.5%
Q3 2015$5,739,000
-31.6%
81,300
+7.7%
0.51%
-17.2%
Q2 2015$8,391,000
+2.6%
75,500
-12.9%
0.62%
+4.5%
Q1 2015$8,176,000
-18.3%
86,700
-2.9%
0.59%
-3.9%
Q4 2014$10,005,00089,3000.62%
Other shareholders
AGIOS PHARMACEUTICALS INC shareholders Q4 2020
NameSharesValueWeighting ↓
Eagle Health Investments LP 431,413$12,558,0003.09%
Casdin Capital, LLC 2,090,000$60,840,0002.73%
Rock Springs Capital Management LP 2,665,275$77,586,0001.95%
Bellevue Group AG 4,129,292$120,204,0001.40%
SUVRETTA CAPITAL MANAGEMENT, LLC 1,177,374$34,273,0001.05%
Altium Capital Management LP 66,196$1,927,0000.64%
ArrowMark Colorado Holdings LLC 1,295,948$37,725,0000.33%
FARALLON CAPITAL MANAGEMENT LLC 1,333,012$38,804,0000.19%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 21,500$707,0000.16%
Virtus ETF Advisers LLC 11,541$336,0000.15%
View complete list of AGIOS PHARMACEUTICALS INC shareholders